乳腺癌 - 医索

找到约 32963 条结果

Molecular residual disease analysis from the ADAURA trial of adjuvant osimertinib in patients with resected EGFR-mutated stage lB-lllA non-small cell lung cancer

医客学院 - 会议报告集

Milestones Early Detection to Nodal Status and Every thing in Between

医客学院 - 会议报告集

Managing Expectations WithAntibody-Drug Conjugates in Non-Small Cell Lung Cancer

医客学院 - 会议报告集

Lorlatinib vs Crizotinib in Treatment-NaivePatients With Advanced ALK Non-SmallCell Lung Cancer 5-Year Progression-FreeSurvival and Safety From the CRoWN Study

医客学院 - 会议报告集

Lorlatinib in TKl naive, advanced RoS1-positivenon-small cell lung cancer a multicenter, open-label, single-arm, phase 2 trial

医客学院 - 会议报告集

Ivonescimab combined with chemotherapy in patientswith EGFR-mutant non-squamous non-small cell lungcancer who progressed on EGFR-TKls treatment arandomized, double-blind, multi-center, phase 3 trial(HARM

医客学院 - 会议报告集

ICARUS-LUNG01 A phase 2 Study of Dato-DXd inpatients with previously treated advanced NSCLc, withsequential tissue biopsies and biomarkers analysis topredict treatment outcome

医客学院 - 会议报告集

Health-Related Quality of Life Outcomes From the Randomized, Double-Blind Phase 3 KEYNOTE-671 Study of Perioperative Pembrolizumab for Early-Stage NSCLC

医客学院 - 会议报告集

Health-related quality of life (HRQoL) results for adjuvant alectinib vs chemotherapy in patients with resected ALK NSCLC data from ALINA

医客学院 - 会议报告集

Global Retrospective Study Comparing Consolidation ALK TKl to Durvalumab or Observation after Chemoradiation in Unresectable Locally Advanced ALK NSCLC

医客学院 - 会议报告集

今日实时热搜